Safety, Tolerability and Biomarker-based Efficacy of NPI-001 (AT-001) in Subjects With MCI or Alzheimer's Disease (AD)
Clinical trial NCT07741526 · ACTIVE_NOT_RECRUITING
Trial details
- NCT number
- NCT07741526
- Sponsor
- Arctic Therapeutics
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2025-10-14
- Primary completion
- 2027-04-30
- Enrollment
- 33
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.